{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreib4sayvw224eofoxau6togstnjha2l44djemvcqbsm5qtiezdtxjm",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mhum6emm5bl2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreih35qedjqbgjyl2r5bcslxsylge6k3hh6ta35pozuzkryeb5vviw4"
    },
    "mimeType": "image/jpeg",
    "size": 119370
  },
  "path": "/2026/03/24/gilead-ouro-galapagos-merck-quotient-ibd-readout-newsletter/?utm_campaign=rss",
  "publishedAt": "2026-03-24T13:26:23.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Business",
    "Pharma",
    "The Readout",
    "biotechnology",
    "drug development",
    "Drug prices",
    "research",
    "STAT+"
  ],
  "textContent": "In today's Readout newsletter: Gilead to acquire an immunology biotech and Merck partners with Flagship company on IBD targets. Plus: Do you have what it takes to be CBER director?",
  "title": "STAT+: Gilead to acquire immunology biotech, offers lifeline to Galapagos",
  "updatedAt": "2026-03-24T13:26:27.000Z"
}